Your session is about to expire
← Back to Search
Dietary Supplement
Vitamin D3 + Omega-3 Fatty Acids for Infections
N/A
Waitlist Available
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year
Awards & highlights
Study Summary
This trial is investigating whether taking daily dietary supplements of vitamin D3 or omega-3 fatty acids reduces the risk of developing cancer, heart disease, and stroke.
Eligible Conditions
- Infections
- Human Cathelicidin Antimicrobial Peptide
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ one year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
hCAP-18
upper respiratory infection
Secondary outcome measures
antimicrobial-treated infection
cellulitis
infection-related hospitalizations
+2 moreTrial Design
4Treatment groups
Active Control
Placebo Group
Group I: vitamin D placebo + fish oilActive Control2 Interventions
vitamin D placebo + Omacor
Group II: vitamin D + fish oilActive Control2 Interventions
vitamin D3 + Omacor
Group III: vitamin D + fish oil placeboActive Control2 Interventions
vitamin D3 + fish oil placebo
Group IV: vitamin D placebo + fish oil placeboPlacebo Group2 Interventions
vitamin D placebo + fish oil placebo
Find a Location
Who is running the clinical trial?
Brigham and Women's HospitalLead Sponsor
1,611 Previous Clinical Trials
11,444,645 Total Patients Enrolled
24 Trials studying Infections
24,542 Patients Enrolled for Infections
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: vitamin D placebo + fish oil
- Group 2: vitamin D + fish oil
- Group 3: vitamin D + fish oil placebo
- Group 4: vitamin D placebo + fish oil placebo
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger